Peutz-Jeghers syndrome: genes and variants
Explore variant evidence for Peutz-Jeghers syndrome across 1 analyzed protein (STK11). Linked ClinVar records include 24 pathogenic or likely pathogenic variants, 605 variants of uncertain significance and 124 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Peutz-Jeghers syndrome
STK11: Serine/threonine-protein kinase STK11
It activates AMPK-family kinases to coordinate cellular energy sensing, polarity, and growth restraint. Germline loss-of-function variants cause Peutz-Jeghers syndrome and its associated cancer predisposition, while somatic loss is common in lung and other cancers.
24 ClinVar pathogenic / likely pathogenic and 729 uncertain variants in STK11 have source records linked to Peutz-Jeghers syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Peutz-Jeghers syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| STK11 R297S | 297 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 R304P | 304 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 N181E | 181 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 N181S | 181 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 N181K | 181 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 R304W | 304 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 W308L | 308 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 W308C | 308 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 D194N | 194 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 H306Y | 306 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 G163R | 163 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 D176N | 176 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 P179R | 179 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 D194E | 194 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 S240W | 240 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 C132R | 132 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 L67P | 67 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 R297G | 297 | Protein kinase | Pathogenic / likely pathogenic (★) |
| STK11 N181D | 181 | Protein kinase | Pathogenic / likely pathogenic (★) |
| STK11 H174P | 174 | Protein kinase | Pathogenic / likely pathogenic (★) |
| STK11 I177N | 177 | Protein kinase | Pathogenic / likely pathogenic (★) |
| STK11 W239C | 239 | Protein kinase | Pathogenic / likely pathogenic (★) |
| STK11 G242R | 242 | Protein kinase | Pathogenic / likely pathogenic (★) |
| STK11 L140P | 140 | Protein kinase | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in Peutz-Jeghers syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| STK11 S240L | 240 | Protein kinase | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; S240W at the same position is pathogenic; REVEL 0.965 |
| STK11 G242V | 242 | Protein kinase | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; G242R at the same position is pathogenic; REVEL 0.970 |
| STK11 H306R | 306 | Protein kinase | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; H306Y at the same position is pathogenic; REVEL 0.843 |
Which prediction tools work for Peutz-Jeghers syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- SIFT: 100 out of 100
- AlphaMissense: 99 out of 100
- ESM1b (LLR): 97 out of 100
- CATVariant: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Peutz-Jeghers syndrome
- Hereditary breast ovarian cancer syndrome, also linked to STK11
- Non-small cell lung carcinoma, also linked to STK11
- Melanoma, cutaneous malignant, also linked to STK11
- Lung adenocarcinoma, also linked to STK11
- Breast and/or ovarian cancer, also linked to STK11
- Familial pancreatic carcinoma, also linked to STK11
- Carcinoma of pancreas, also linked to STK11
- Germ cell tumor of testis, also linked to STK11
- Malignant tumor of testis, also linked to STK11
Frequently asked questions
Which genes have records linked to Peutz-Jeghers syndrome?
This view contains 1 analyzed proteins: STK11. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 24 pathogenic or likely pathogenic variants, 605 variants of uncertain significance and 124 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 775 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center